Millions of lives are lost each year to viral diseases. Clear Creek Bio's highly experienced team is passionate about rapidly developing safe, effective, and easy-to-administer therapeutics.
Clear Creek Bio is a clinical-stage biotech developing oral antivirals. We focus on host-targeting and direct-acting small molecule antiviral therapeutics targeting SARS-CoV-2 and other medically important viruses.
Translating new insights in viral mechanisms, targeting both host and viral pathways.
The Clear Creek Bio team has successfully driven antiviral drug development from discovery through approval.